JPMorgan Chase & Co’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329 | Buy |
215
+179
| +497% | +$274 | ﹤0.01% | 5852 |
|
|
2025
Q1 | $44 | Sell |
36
-2
| -5% | -$2 | ﹤0.01% | 6127 |
|
|
2024
Q4 | $119 | Hold |
38
| – | – | ﹤0.01% | 5930 |
|
|
2024
Q3 | $107 | Hold |
38
| – | – | ﹤0.01% | 5921 |
|
|
2024
Q2 | $206 | Hold |
38
| – | – | ﹤0.01% | 5757 |
|
|
2024
Q1 | $164 | Buy |
38
+5
| +15% | +$22 | ﹤0.01% | 5819 |
|
|
2023
Q4 | $182 | Sell |
33
-801
| -96% | -$4.42K | ﹤0.01% | 6022 |
|
|
2023
Q3 | $3.84K | Buy |
834
+711
| +578% | +$3.27K | ﹤0.01% | 5469 |
|
|
2023
Q2 | $381 | Hold |
123
| – | – | ﹤0.01% | 5660 |
|
|
2023
Q1 | $0 | Sell |
123
-1
| -0.8% | – | ﹤0.01% | 6013 |
|
|
2022
Q4 | $0 | Sell |
124
-5
| -4% | – | ﹤0.01% | 5797 |
|
|
2022
Q3 | $0 | Buy |
129
+5
| +4% | – | ﹤0.01% | 5710 |
|
|
2022
Q2 | $0 | Hold |
124
| – | – | ﹤0.01% | 5784 |
|
|
2022
Q1 | $0 | Hold |
124
| – | – | ﹤0.01% | 5857 |
|
|
2021
Q4 | $1K | Hold |
124
| – | – | ﹤0.01% | 5645 |
|
|
2021
Q3 | $2K | Hold |
124
| – | – | ﹤0.01% | 5386 |
|
|
2021
Q2 | $4K | Sell |
124
-3,624
| -97% | -$117K | ﹤0.01% | 5322 |
|
|
2021
Q1 | $83K | Sell |
3,748
-2,306
| -38% | -$51.1K | ﹤0.01% | 4690 |
|
|
2020
Q4 | $87K | Buy |
6,054
+4,851
| +403% | +$69.7K | ﹤0.01% | 4337 |
|
|
2020
Q3 | $19K | Buy |
1,203
+107
| +10% | +$1.69K | ﹤0.01% | 4498 |
|
|
2020
Q2 | $23K | Buy |
1,096
+127
| +13% | +$2.67K | ﹤0.01% | 4390 |
|
|
2020
Q1 | $18K | Sell |
969
-21
| -2% | -$390 | ﹤0.01% | 4378 |
|
|
2019
Q4 | $29K | Buy |
990
+2
| +0.2% | +$59 | ﹤0.01% | 4363 |
|
|
2019
Q3 | $50K | Buy |
988
+144
| +17% | +$7.29K | ﹤0.01% | 4256 |
|
|
2019
Q2 | $65K | Buy |
+844
| New | +$65K | ﹤0.01% | 4163 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4924 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4843 |
|